Your browser doesn't support javascript.
loading
Increasing incidence of lentigo maligna and lentigo maligna melanoma in Catalonia.
Matas-Nadal, Clara; Malvehy, Josep; Ferreres, Jose Ramon; Boada, Aram; Bodet, Domingo; Segura, Sonia; Salleras, Montse; Azon, Antoni; Bel-Pla, Susana; Bigata, Xavier; Campoy, Antoni; Curcó, Neus; Dalmau, Joan; Formigon, Manel; Gonzalez, Alberto; Just, Miquel; Llistosella, Enric; Nogues, M Elena; Pedragosa, Ramon; Pujol, Josep A; Sabat, Mireia; Smandia, Joan A; Zaballos, Pedro; Puig, Susana; Martí, Rosa M.
Affiliation
  • Matas-Nadal C; Department of Dermatology, Hospital Universitari Arnau de Vilanova, University of Lleida, IRBLleida, Lleida & CIBERONC, Lleida, Spain.
  • Malvehy J; Department of Dermatology, Hospital Clínic de Barcelona (Melanoma Unit), University of Barcelona, IDIBAPS, Barcelona & CIBERER, Barcelona, Spain.
  • Ferreres JR; Department of Dermatology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.
  • Boada A; Department of Dermatology, Universitari Germans Trias i Pujol, Badalona, Spain.
  • Bodet D; Department of Dermatology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Segura S; Department of Dermatology, Hospital del Mar, IMIM, Barcelona, Spain.
  • Salleras M; Department of Dermatology, Hospital Universitari Sagrat Cor, Barcelona, Spain.
  • Azon A; Department of Dermatology, Hospital Universitari Sant Joan de Reus, Reus, Spain.
  • Bel-Pla S; Department of Dermatology, Hospital Comarcal d'Amposta, Amposta, Spain.
  • Bigata X; Department of Dermatology, Hospital de Mataró, Mataró, Spain.
  • Campoy A; Department of Dermatology, Hospital General de Catalunya, Sant Cugat, Spain.
  • Curcó N; Department of Dermatology, Hospital Universitari Mútua Terrassa, Terrassa, Spain.
  • Dalmau J; Department of Dermatology, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
  • Formigon M; Department of Dermatology, Consorci Sanitari de Terrassa, Terrassa, Spain.
  • Gonzalez A; Department of Dermatology, Consorci Sanitari Integral, L'Hospitalet de Llobregat, Spain.
  • Just M; Department of Dermatology, Hospital de Figueres, Figueres, Girona, Spain.
  • Llistosella E; Department of Dermatology, Hospital Universitari Dr. Josep Trueta, Girona, Spain.
  • Nogues ME; Department of Dermatology, Hospital d'Igualada, Igualada, Barcelona, Spain.
  • Pedragosa R; Department of Dermatology, Hospital Plató, Barcelona, Spain.
  • Pujol JA; Department of Dermatology, Hospital Universitari Joan XXIII, Tarragona, Spain.
  • Sabat M; Department of Dermatology, Hospital Parc Taulí, Sabadell, Spain.
  • Smandia JA; Department of Dermatology, Hospital 2 de Maig, Barcelona, Spain.
  • Zaballos P; Department of Dermatology, Hospital de Santa Tecla, Tarragona, Spain.
  • Puig S; Department of Dermatology, Hospital Clínic de Barcelona (Melanoma Unit), University of Barcelona, IDIBAPS, Barcelona & CIBERER, Barcelona, Spain.
  • Martí RM; Department of Dermatology, Hospital Universitari Arnau de Vilanova, University of Lleida, IRBLleida, Lleida & CIBERONC, Lleida, Spain.
Int J Dermatol ; 58(5): 577-581, 2019 May.
Article in En | MEDLINE | ID: mdl-30548854
ABSTRACT

BACKGROUND:

Recent epidemiological studies suggest that past data where superficial spreading melanoma was by far the most common subtype of melanoma may not reflect current patterns of sun exposure or other risk factors more involved in other subtypes of melanoma as lentigo maligna (LM) or lentigo maligna melanoma (LMM).

METHODS:

In order to measure the current situation in our country, all cases of LM and LMM diagnosed in 23 hospitals in Catalonia, from 2000 to 2007, were recorded.

RESULTS:

Although for the global period LM/LMM represented only 8.4% of cases, an increasing trend in this percentage was observed throughout the study period (from 6.9% [27 cases] in 2000 to 13.1% [94 cases] in 2007). Also, an increasing incidence of LM/LMM was observed, especially in chronically sun-exposed areas (85.5% involving the head and neck region). During the 8 years of the registry, the mean Breslow thickness of LMM remained stable. However, the increase in the number of LM (in situ) cases was significantly higher than the increase of the invasive ones.

CONCLUSIONS:

An important observation from this data is that aging of population and current sun exposure patterns could keep increasing the incidence of LM/LMM, which may become an important public healthcare problem, over the other histological subtypes. In order to establish primary or secondary preventive measures to the LM/LMM risk-population, it is imperative to highlight the importance of chronic sun damage as a melanoma risk factor, and not only sunburn, most commonly addressed in melanoma prevention campaigns.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Hutchinson's Melanotic Freckle Type of study: Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Int J Dermatol Year: 2019 Document type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Hutchinson's Melanotic Freckle Type of study: Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Int J Dermatol Year: 2019 Document type: Article Affiliation country: Spain